|
MechanismCD11a antagonists |
Active Org.- |
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.FR |
First Approval Date01 Jan 1997 |
Target- |
MechanismImmunomodulators |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism5-HT1B receptor agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Immunotech
0 Patents (Medical) associated with Immunotech
100 Deals associated with Immunotech
100 Translational Medicine associated with Immunotech